A man is worried his home might kill him after claiming black mould in the property hit him with a deadly fungal lung disease ...

Fosmanogepix is under clinical development by Basilea Pharmaceutica and currently in Phase II for Unspecified Fungal Infections.

Centers for Disease Control and Prevention. Risk factors for fungal diseases. MedlinePlus. Tinea infections. MedlinePlus. Familial candidiasis. Cleveland Clinic. Cryptococcosis. Centers for Disease ...

Ibrexafungerp citrate (SCY-078) is under development for the treatment of invasive pulmonary aspergillosis, fungal infections, candidiasis (including systemic and invasive), invasive aspergillosis, ...

[42] Physicians dealing with immunodeficient hosts face the issue of optimal management for invasive aspergillosis ... investigated to treat invasive fungal infections. Favorable response rate ...

Matthew Langsworth, from Leamington Spa, Warwickshire, warned his landlord of the extensive spores within his property, but ...

The treatment of invasive fungal infections is complicated by both ... and liposomal amphotericin B in 30 patients with invasive aspergillosis found that 17 of these patients had a total of ...

Matthew Langsworth says he breathed in fungal spores for a decade, alleging that his landlord painted over black mold instead ...

Fungal infection can activate both innate and adaptive immune responses in the cornea. Fungi stimulate the production of oxidative stress-related biomarkers and mediate the infiltration of neutrophils ...

Invasive fungal diseases (IFDs) are a growing threat to human health ... Immunochromatography technologies have ushered a new era of point-of-care diagnostics for Aspergillus, Cryptoccocus, and ...